518 related articles for article (PubMed ID: 15173268)
21. Metabolites of a tobacco-specific carcinogen in urine from newborns.
Lackmann GM; Salzberger U; Töllner U; Chen M; Carmella SG; Hecht SS
J Natl Cancer Inst; 1999 Mar; 91(5):459-65. PubMed ID: 10070946
[TBL] [Abstract][Full Text] [Related]
22. Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco.
Hecht SS; Carmella SG; Edmonds A; Murphy SE; Stepanov I; Luo X; Hatsukami DK
Tob Control; 2008 Apr; 17(2):128-31. PubMed ID: 18375734
[TBL] [Abstract][Full Text] [Related]
23. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users.
Stepanov I; Carmella SG; Han S; Pinto A; Strasser AA; Lerman C; Hecht SS
Nicotine Tob Res; 2009 Jan; 11(1):99-105. PubMed ID: 19246447
[TBL] [Abstract][Full Text] [Related]
24. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
[TBL] [Abstract][Full Text] [Related]
25. Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users.
Benowitz NL; Renner CC; Lanier AP; Tyndale RF; Hatsukami DK; Lindgren B; Stepanov I; Watson CH; Sosnoff CS; Jacob P
Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):934-42. PubMed ID: 22490317
[TBL] [Abstract][Full Text] [Related]
26. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
[TBL] [Abstract][Full Text] [Related]
27. NNAL exposure by race and menthol cigarette use among U.S. smokers.
Rostron B
Nicotine Tob Res; 2013 May; 15(5):950-6. PubMed ID: 23089487
[TBL] [Abstract][Full Text] [Related]
28. Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial.
Mercincavage M; Lochbuehler K; Wileyto EP; Benowitz NL; Tyndale RF; Lerman C; Strasser AA
JAMA Netw Open; 2018 Aug; 1(4):e181346. PubMed ID: 30627706
[TBL] [Abstract][Full Text] [Related]
29. Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study.
Shahab L; Goniewicz ML; Blount BC; Brown J; McNeill A; Alwis KU; Feng J; Wang L; West R
Ann Intern Med; 2017 Mar; 166(6):390-400. PubMed ID: 28166548
[TBL] [Abstract][Full Text] [Related]
30. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
[TBL] [Abstract][Full Text] [Related]
31. Effect of Pod e-Cigarettes vs Cigarettes on Carcinogen Exposure Among African American and Latinx Smokers: A Randomized Clinical Trial.
Pulvers K; Nollen NL; Rice M; Schmid CH; Qu K; Benowitz NL; Ahluwalia JS
JAMA Netw Open; 2020 Nov; 3(11):e2026324. PubMed ID: 33206193
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers of Exposure for Dual Use of Electronic Cigarettes and Combustible Cigarettes: Nicotelline, NNAL, and Total Nicotine Equivalents.
Jacob P; St Helen G; Yu L; Nardone N; Havel C; Cheung P; Benowitz NL
Nicotine Tob Res; 2020 Jun; 22(7):1107-1113. PubMed ID: 31833541
[TBL] [Abstract][Full Text] [Related]
33. Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.
Hecht SS; Stepanov I; Carmella SG
Acc Chem Res; 2016 Jan; 49(1):106-14. PubMed ID: 26678241
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users.
Hecht SS; Carmella SG; Stepanov I; Jensen J; Anderson A; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):732-5. PubMed ID: 18349296
[TBL] [Abstract][Full Text] [Related]
35. [Harm reduction strategy in tobacco control].
Gorini G
Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
[TBL] [Abstract][Full Text] [Related]
36. Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users.
Wagener TL; Floyd EL; Stepanov I; Driskill LM; Frank SG; Meier E; Leavens EL; Tackett AP; Molina N; Queimado L
Tob Control; 2017 Mar; 26(e1):e23-e28. PubMed ID: 27729564
[TBL] [Abstract][Full Text] [Related]
37. The relationship between nicotine metabolism and nicotine and carcinogen exposure among American Indian commercial cigarette smokers and electronic nicotine delivery system users.
Carroll DM; Wagener TL; Stephens LD; Brame LS; Thompson DM; Beebe LA
Addict Behav; 2019 May; 92():58-63. PubMed ID: 30583092
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon-filtered cigarettes in short-term and long-term clinical studies.
Sarkar M; Kapur S; Frost-Pineda K; Feng S; Wang J; Liang Q; Roethig H
Nicotine Tob Res; 2008 Dec; 10(12):1761-72. PubMed ID: 19023827
[TBL] [Abstract][Full Text] [Related]
39. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
Joseph AM; Hecht SS; Murphy SE; Carmella SG; Le CT; Zhang Y; Han S; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2963-8. PubMed ID: 16365017
[TBL] [Abstract][Full Text] [Related]
40. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA
J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
